Zhongyi Cheng
- Molecular Biology top 1%
- Geriatrics and Gerontology top 0.1%
- Oncology top 5%
- Epidemiology top 5%
- Cancer Research top 5%
- Topics
- Sirtuins and Resveratrol in Medicine (14 papers)Ubiquitin and proteasome pathways (11 papers)Peptidase Inhibition and Analysis (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zhongyi Cheng
59 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 4.5k
- Geriatrics and Gerontology 1.1k
- Oncology 895
- Epidemiology 764
- Cancer Research 493
Countries citing papers authored by Zhongyi Cheng
This map shows the geographic impact of Zhongyi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongyi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongyi Cheng more than expected).
Fields of papers citing papers by Zhongyi Cheng
This network shows the impact of papers produced by Zhongyi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongyi Cheng. The network helps show where Zhongyi Cheng may publish in the future.
Co-authorship network of co-authors of Zhongyi Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Zhongyi Cheng. A scholar is included among the top collaborators of Zhongyi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongyi Cheng. Zhongyi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 28 | |
| 6 | 5 | |
| 7 | 13 | |
| 8 | 34 | |
| 9 | 8 | |
| 10 | 9 | |
| 11 | 90 | |
| 12 | 44 | |
| 13 | 13 | |
| 14 | 36 | |
| 15 | 314 | |
| 16 | 12 | |
| 17 | 78 | |
| 18 | 178 | |
| 19 | Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modificationbreakdown → | 1385 |
| 20 | The First Identification of Lysine Malonylation Substrates and Its Regulatory Enzymebreakdown → | 597 |
About Zhongyi Cheng
Zhongyi Cheng is a scholar working on Geriatrics and Gerontology, Molecular Biology and Aging, having authored 63 papers that have together received 6.0k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (14 papers), Ubiquitin and proteasome pathways (11 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Geriatrics and Gerontology (1.1k citations), Molecular Biology (4.5k citations) and Microbiology (313 citations). Zhongyi Cheng has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yingming Zhao, Minjia Tan, Zhike Lu, Jeong Soo Yang, Hao Luo, Yang Ye, Junbiao Dai, Zhongyu Xie, Sangkyu Lee and Bing Ren. Their work appears in journals such as Cell, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.